5 Interesting Startup Deals You May Have Missed In December: A Hospital-Grade Wireless Heart Monitor, AI-Designed Proteins For Manufacturing, And More
Summary
Five startups recently secured significant funding rounds, highlighting diverse applications of AI and advanced technology. Inito raised $29 million in Series B funding to expand its at-home hormone health testing beyond fertility, utilizing AI-engineered antibodies for broader diagnostics. Assaia, a Zurich-based startup, secured $26.6 million in Series B funding for its AI-driven platform that optimizes airport operations, currently deployed at major hubs like JFK and Heathrow. Aether Bio announced $15 million in new funding for manufacturing novel materials using AI-developed proteins, with its first product, RapidPrint, a 3D printing polymer filament. Wearlinq received $14 million in Series A funding for its FDA 510(k) cleared wireless heart monitor, aiming to scale its hospital-grade at-home monitoring. Lastly, Built AI, a London-based proptech startup, closed a $6 million seed round to expand its machine learning platform for commercial real estate financial modeling into the U.S. market, having already analyzed $70 billion in opportunities.
Key takeaway
For AI Product Managers evaluating market opportunities, consider the high-impact applications demonstrated by these funded startups. Focus on areas where AI can significantly reduce operational friction, enhance diagnostic precision, or accelerate material innovation. Your next product could leverage AI-engineered solutions to address critical needs in healthcare, logistics, or industrial manufacturing, offering substantial value and market differentiation.
Key insights
AI and advanced biological engineering are driving innovation across health diagnostics, logistics, materials science, and real estate.
Principles
- AI-engineered proteins enhance diagnostic accuracy.
- AI optimizes complex operational workflows.
- AI can accelerate material design and manufacturing.
Method
Inito uses computer models to predict protein folding and design synthetic antibodies. Aether Bio combines purpose-built AI with high-throughput robotics to design molecular assemblers. Built AI uses machine learning to extract and analyze building data for financial modeling.
In practice
- Develop AI-designed antibodies for new diagnostic tests.
- Implement AI platforms to streamline airport turnaround times.
- Utilize AI-optimized materials for faster 3D printing.
Topics
- AI-engineered Antibodies
- AI-driven Airport Operations
- AI-designed Proteins
- Commercial Real Estate AI
- Digital Health Monitoring
Best for: Investor, Entrepreneur, AI Product Manager
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by Artificial intelligence - Crunchbase News.